Pituitary responsiveness to GH-releasing hormone, GH-releasing peptide-2 and thyrotrophin-releasing hormone in critical illness

Clinical Endocrinology

Volumn 45, Issue 3, 1996, Pages 341-351

  Van Den Berghe, Greet ^a   De Zegher, Francis ^a   Bowers, Cyril Y ^b   Wouters, Pieter ^a   Muller, Peter ^a   Soetens, Filip ^a   Vlasselaers, Dirk ^a   Schetz, Miet ^a   Verwaest, Charles ^a   Lauwers, Peter ^a   Bouillon, Roger ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; LIOTHYRONINE; PROLACTIN; PROTIRELIN; SOMATOMEDIN C; THYROTROPIN; THYROXINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICAL ILLNESS; CROSSOVER PROCEDURE; FEMALE; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 9544232545     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1996.00805.x     Document Type: Article

References (66)

1. 2) in rat anterior pituitary cells. Journal of Endocrinology, 132, 1286-1291.
2. Arem, R., Wiener, G.J., Kaplan, S.G., Kim, H.S., Reichlin, S. & Kaplan, M.M. (1993) Reduced tissue thyroid hormone levels in fatal illness. Metabolism, 42, 1102-1108.
3. Barinaga, M., Yamonoto, G., Rivier, G., Vale, W., Evans, R. & Rosenfeld, M.G. (1983) Transcriptional regulation of growth hormone gene expression by growth hormone-releasing factor. Nature, 306, 84-85.
4. 2 analog in normal men. Peptides, 6, 575-577.
5. Berelowitz, M., Szabo, M., Frohman, L.A., Firestone, S., Chu, L. & Hintz, R.L. (1985) Somatomedin-C mediates growth hormone negative feedback by effects on both the hypothalamus and the pituitary. Science, 230, 461-463.
6. Bouillon, R. & De Moor, P. (1974) Heterogeneity of human growth hormone in serum. Annales d'Endocrinologie, 35, 606-613.
7. Bowers, C.Y., Momany, F.A., Reynolds, G.A. & Hong, A. (1984) On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. Endocrinology, 114, 1537-1545.
8. Bowers, C.Y., Reynolds, G.A., Durham, D., Barrere, C.M., Pezzoli, S.S. & Thorner, M.O. (1990) Growth hormone (GH)-releasing peptide stimulates GH release in normal men and acts synergistically with GH-releasing hormone. Journal of Clinical Endocrinology and Metabolism, 70, 975-982.
9. Bowers, C.Y., Sartor, A.O., Reynolds, G.A. & Badger, T.M. (1991) On the actions of the growth hormone-releasing hexapeptide, GHRP. Endocrinology, 128, 2027-2035.
10. Civetta, J.M., Taylor, R.W. & Kirby, R.R. (1992) Critical Care. J.B. Lippincott Company, Philadelphia.
11. Cohen, R., Bouquier, D., Biot-Laporte, S., Vermeulen, E., Claustrat, B., Cherpin, M.H., Cabrera, P., Guidetti, P., Ferry, S., Bizollon, Ch.A. & Sassolas, G. Pituitary stimulation by combined administration of four hypothalamic releasing hormones in normal men and patients. (1986) Journal of Clinical Endocrinology and Metabolism, 62, 892-898.
12. Devins, S.S., Miller, A., Herndon, B.L., O'Toole, L. & Reisz, G. (1992) Effects of dopamine on T-lymphocyte proliferative responses and serum prolactin concentrations in critically ill patients. Critical Care Medicine, 263, 9682-9685.
13. Docter, R., Krenning, E.P., de Jong, M. & Henneman, G. (1993) The sick euthyroid syndrome: changes in thyroid hormone serum parameters and hormone metabolism. Clinical Endocrinology, 39, 499-518.
14. Elia, M. (1995) Changing concepts of nutrient requirements in disease: implications for artificial nutritional support. Lancet, 345, 1279-1284.
15. Frieboes, R.-M., Murek, H., Maier, P., Schrier, T., Holsboer, F. & Steiger, A. (1995) Growth hormone-releasing peptide-6 stimulates sleep, growth hormone, ACTH and cortisol in normal man. Neuroendocrinology, 61, 584-589.
16. Ghahary, A., Fu, S., Shen, Y.J., Shankowsky, H.A. & Tredget, E.E. (1994) Differential effects of thermal injury on circulating insulin-like growth factor binding proteins in burn patients. Molecular and Cellular Biochemistry, 135, 171-180.
17. Giustina, A., Bussi, A.R., Deghenghi, R., Imbimbo, B., Licini, M., Poiesis, C. & Wehrenberg, W.B. (1995) Comparison of the effects of growth hormone-releasing hormone and hexarelin, a novel growth hormone-releasing peptide-6 analog, on growth hormone secretion in humans with or without glucocorticoid excess. Journal of Endocrinology, 146, 227-23.2
18. Goldman, J.A., Molitch, M.E., Thorner, M.O., Vale, W., Rivier, J. & Reichlin, S. (1987) Growth hormone and prolactin responses to bolus and sustained infusions of GHRH-1-40-OH in man. Journal of Endocrinological Investigation, 10, 397-406.
19. Goth, M.I., Lyons, C.E., Canny, B.J. & Thorner, M.O. (1992) Pituitary adenylate cyclase activating polypeptide, growth hormone (GH)-releasing peptide and GH-releasing hormone stimulate GH release through distinct pituitary receptors. Endocrinology, 130, 939-944.
20. Heinen, E., Herrmann, J., Königshausen, Th. & Krüskemper, H.L. (1981) Secondary hypothyroidism in severe non thyroidal illness? Hormone and Metabolic Research, 13, 284-288.
21. Herndon, D.N., Barrow, R.E., Kunkel, K.R., Broemeling, L. & Rutal, R.L. (1990) Effects of recombinant human growth hormone on donor-site healing in severely burned children. Annals of Surgery, 12, 424-431.
22. Holl, R.W., Thorner, M.O. & Leong, D.A. (1988) Intracellular calcium concentration and growth hormone secretion in individual somatotropes: effect of growth hormone-releasing factor and somatostatin. Endocrinology, 122, 2927-2932.
23. Imbimbo, B.P., Mant, T., Edwards, M., Amin, D., Dalton, N., Boutignon, F., Lenaerts, V., Wüthrich, P. & Deghenghi, R. (1994) Growth hormone-releasing activity of hexarelin in humans: a dose-response study. European Journal of Clinical Pharmacology, 46, 421-425.
24. Jackson, I.M.D. (1982) Thyrotropin releasing hormone. The New England Journal of Medicine, 306, 145-155.
25. Jeevanandam, M., Holaday, N.J. & Petersen, S.R. (1995) Plasma levels of Insulin-like growth factor binding protein-3 in acute trauma patients. Metabolism, 44, 1205-1208.
26. Kinney, J.M. (1995) Metabolic responses of the critically ill patient. In Critical Care Clinics. Nutrition in the critically ill patient. (eds. C.H. Lang & N.N. Abumrad), pp 569-587. W.B. Saunders Company, Philadelphia.
27. Korbonits, M. & Grossman, A.B. (1995) Growth hormone-releasing peptide and its analogues. Novel stimuli to growth hormone release. Trends in Enocrinology and Metabolism, 6, 43-49.
28. Kupfer, S.R., Underwood, Baxter, R.C. & Clemmons, D.R. (1993) Enhancement of the anabolic effects of growth hormone and insulin-like growth factor-1 by use of both agents simultaneously. Journal of Clinical Investigation, 91, 391-396.
29. Levy, E.M., Alharbi, S.A., Grindlinger, G. & Black, P.H. (1984) Changes in mitogen responsiveness and lymphocyte subsets after traumatic injury: relation to development of sepsis. Clinical Immunology and Immunopathology, 32, 224-233.
30. Loche, S., Cambioso, P., Carta, D., Setzu, S., Imbimbo, B.P., Borrelli, P., Pintor, C. & Cappa, M. (1995) The growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, in short normal and obese children and in hypopituitary subjects. Journal of Clinical Endocrinology and Metabolism, 80, 674-678.
31. Looij, B.J., Nieuwenhuijzen Kruseman, A.C., Mudde, A.H., Frölich, M., Piaditis, G.P., Hodgknison, S.C., McLean, C., Grossman, A., Coy, D.H., Rees, L.H., Lowry, P.J. & Besser, G.M. (1986) The interaction of growth hormone releasing hormone with other hypothalamic hormones on the release of anterior pituitary hormones. Clinical Endocrinology, 24, 149-156.
32. Looij, B.J., Roelfsema, F., Fröloch, M. & Nieuwenhuijzen Kruseman, A.C. (1991) The interaction of GHRH with TRH in acromegaly: a controlled study. Acta Endocrinologica (Copenh), 125, 337-341.
33. Maccario, M., Arvat, E., Procopio, M., Gianotti, L., Imbimbo, B.P., Lenaerts, V., Deghenghi, R., Camanni, F. & Ghigo, E. (1995) Metabolic modulation of the growth hormone-releasing activity of hexarelin in man. Metabolism, 44, 134-138.
34. Massoud, A.F., Hindmarsh, P.C., Pringle, P.J. & Brook, C.G.D. (1995) Are the actions of growth hormone-releasing peptides really specific? Program of the 77th Endocrine Society Meeting, Washington, p 54.
35. McRitchie, D.I., Girotti, M.J., Rotstein, O.D. & Teodorczyk-Injeyan, J.A. (1990) Impaired antibody production in blunt trauma: possible role for T-cell function. Archives of Surgery, 11, 428-435.
36. Meakins, J.L., Pietsch, J.B., Bubenick, O., Kelly, R., Rode, H., Gordon, J., MacLean, L.D. (1977) Delayed hypersensitivity: indicator of acquired failure of host defenses in sepsis and trauma. Annals of Surgery, 188, 241-250.
37. Meert, K.L., Long, M.L., Kaplan, J. & Sarnaik, A.P. (1995) Alterations in immune function following head injury in children. Critical Care Medicine, 23, 822-828.
38. Mizock, B.A. (1995) Alterations in carbohydrate metabolism during stress: a review of the literature. American Journal of Medicine, 98, 75-84.
39. Momany, F.A., Bowers, C.Y., Reynolds, G.A., Hing, A. & Newlander, K. (1984) Conformational energy studies and in vitro and in vivo activity data on growth hormone-releasing peptides. Endocrinology, 114, 1531-1536.
40. Murphy, W.J., Rui, H. & Longo, D.L. (1995) Minireview: effects of growth hormone and prolactin: immune development and function. Life Sciences, 57, 1-14.
41. Penalva, A., Carballo, A., Pombo, M., Casanueva, F.F. & Dieguez, C. (1993) Effects of growth hormone (GH)-releasing hormone, atropine, pyridostigmine, or hypoglycemia on GHRP-6-induced GH secretion in man. Journal of Clinical Endocrinology and Metabolism, 76, 168-171.
42. Pombo, M., Barreiro, J., Penalva, A., Peino, R., Dieguez, C. & Casanueva, F.F. (1995) Absence of growth hormone (GH) secretion after the administration of either GH-releasing hormone (GHRH). GH-releasing peptide (GHRP-6), or GHRH plus GHRP-6 in children with neonatal pituitary stalk transsection. Journal of Clinical Endocrinology and Metabolism, 80, 3180-3185.
43. Reichlin, S. (1992) Neuroendocrinology. In Williams Textbook of Endocrinology (eds J.D. Wilson & D.W. Foster), pp. 135-219. W.B. Saunders, Philadelphia.
44. Reichlin, S. (1993) Neuroendocrine-immune interactions. New England Journal of Medicine, 329, 1246-1253.
45. Ross, R., Miell, J., Freeman, E., Jones, J., Matthews, D., Preece, M. & Buchanan, C. (1991a) Critically ill patients have high basal growth hormone levels with attenuated oscillatory activity associated with low levels of insulin-like growth factor-1. Clinical Endocrinology, 35, 47-54.
46. Ross, R.J.M., Miell, J.P., Holly, J.M.P., Maheshwari, H., Norman, M., Abdulla, A.F. & Buchanan, C.R. (1991b) Levels of GH-binding activity, IGFBP-1. insulin, blood glucose and cortisol in intensive care patients. Clinical Endocrinology, 35, 361-367.
47. Snyder, P.J. & Utiger, R.D. (1972) Response to thyrotropin releasing hormone (TRH) in normal man. Journal of Clinical Endocrinology and Metabolism, 34, 380-385.
48. Spoudeas, H.A., Winrow, A.P., Hindmarsh, P.C. & Brook, C.G.D. (1994) Low-dose growth hormone-releasing hormone test: a dose-response study. European Journal of Endocrinology, 131, 238-245.
49. Streat, S.J., Beddoe, A.H. & Hill, G.L. (1987) Aggressive nutritional support does not prevent protein loss despite fat gain in septic intensive care patients. Journal of Trauma, 21, 262-266.
50. Sumita, S., Ujike, Y., Namiki, A., Watanabe, H., Kawanaba, A. & Satoh, O. (1994) Suppression of the thyrotropin response to thyrotropin-releasing hormone and its association with severity of critical illness. Critical Care Medicine, 22, 1603-1609.
51. Talwar, K.K., Sawhney, R.C. & Rastogi, G.K. (1977) Serum levels of thyrotropin, thyroid hormones and their response to thyrotropin releasing hormone in infective febrile illnesses. Journal of Clinical Endocrinology and Metabolism, 44, 398-403.
52. Thorner, M.O., Vance, M.L., Hartman, M.L., Holl, R.W., Evans, W.S., Veldhuis, J.D., Van Cauter, E., Copinschi, G., Bowers, C.Y. (1990) Physiological role of somatostatin on growth hormone regulation in humans. Metabolism, 39, 40-42.
53. Thorner, M.O., Vance, M.L., Horvath, E. & Kovacs, K. (1992) The anterior pituitary gland. In Williams Textbook of Endocrinology (eds J.D. Wilson & D.W. Foster), pp. 221-310. W.B. Saunders, Philadelphia.
54. Tiulpakov, A.N., Brook, C.G.D., Pringle, P.J., Peterkova, V.A., Volevodz, N.N. & Bowers, C.Y. (1995) GH reponses to intravenous bolus infusions of GH releasing hormone and GH releasing peptide 2 seperately and in combination in adult volunteers. Clinical Endocrinology, 43, 347-350.
55. Van den Berghe, G., de Zegher, F., Lauwers, P. & Veldhuis, J.D. (1994a) Growth hormone secretion in critical illness: effect of dopamine. Journal of Clinical Endocrinology and Metabolism, 79, 1141-1146.
56. Van den Berghe, G., de Zegher, F., Lauwers, P. & Veldhuis, J.D. (1994b) Luteinizing hormone secretion and hypoandrogenemia in critically ill men: effect of dopamine. Clinical Endocrinology, 41, 563-569.
57. Van den Berghe, G., de Zegher, F. & Lauwers, P. (1994c) Dopamine and the sick euthyroid syndrome in critical illness. Clinical Endocrinology, 41, 731-737.
58. Van den Berghe, G., de Zegher, F. & Lauwers, P. (1994d) Dopamine suppresses pituitary function in infants and children. Critical Care Medicine, 22, 1747-1753.
59. Van den Berghe, G., de Zegher, F., Vanhaecke, J., Verleden, G. & Lauwers, P. (1994e) Growth hormone as rescue treatment after heart-lung or double lung transplantation. Endocrinology and Metabolism, 1, 187-190.
60. Van den Berghe, G., de Zegher, F., Vlasselaers, D., Sehetz, M., Verwaest, C., Ferdinande, P. Lauwers, P. (1996) Thyrotropin Releasing Hormone in critical illness: from a dopamine-dependent test to a strategy for increasing low serum triiodothyronine, prolactin and growth hormone. Critical Care Medicine, 24, 590-595.
61. Vierhapper, H., Laggner, A., Waldhäuserl, W., Grubeek-Loebenstein, B. & Kleinberger G. (1982) Impaired secretion of TSH in critically ill patients with low T4-syndrome. Acta Endocrinologica, 101, 542-549.
62. Voerman, B.J., Strack van Schijndel, R.L.M., Groeneveld, A.B.J., de Boer, H., Nauta, J.P. & Thijs, L.G. (1995) Effects of human growth hormone in critically ill nonseptic patients: results from a prospective, randomized, placebo-controlled trial. Critical Care Medicine, 23, 665-67.
63. Wartofski, L. & Burman, K.D (1982) Alterations in thyroid function in patients with systemic illness: the 'euthyroid sick syndrome'. Endocrine Reviews, 3, 164-167.
64. Wilmore, D.W. (1991) Catabolic illness. Strategies for enhancing recovery. New England Journal of Medicine, 325, 695-702.
65. Wilmore, D.W. (1995) Growth hormone and growth factors in catabolic illness. Endocrinology and Metabolism, 2(Suppl. B), 77-84.
66. Wilmore, D.W. & Carpentier, Y.A. (volume eds) (1993) Metabolic support of the critically ill patient. Update in intensive care and emergency medicine. Volume 17, Springer-Verlag, Berlin Heidelberg.